Tagged biotech
Press Release
Nemysis Ltd Strengthens Its Scientific Advisory Board With Nutritional and Pharmaceutical Solutions Expert Linda Cavaletti
Nemysis Ltd today announces the appointment of internationally recognized drug discovery and development expert Linda Cavaletti to its Scientific Advisory Board (SAB). Read More
Press Release
Remiges Ventures Closes Second Fund With $95 Million; Launches RDiscovery Incubator
Remiges Ventures, a US-based cross-border venture capital firm with offices in Seattle, WA and Tokyo, Japan, announced today the final closing of its second fund, Remiges BioPharma Fund II raising a total of $95 million, and the launch of RDiscovery, a new life sciences incubator to nurture and advance early-stage therapeutic concepts and technologies. Read More
Press Release
5th Stanford Drug Discovery Symposium (SDDS 2021) to be Held Virtually This Year on April 19-20, 2021
There is free registration for all interested attendees: http://tinyurl.com/SDDS2021. Co-Sponsored by the Stanford Cardiovascular Institute, Stanford Cancer Institute, Stanford Cardiovascular Health, and many others. Read More
Press Release
Nemysis Granted Patent on Its Nano-Particulate Oral Iron Product (IHAT) in South Africa
Nemysis Limited, the Dublin based pharmaceutical and healthcare Company, focused on Iron Deficiency/Anemia and Gluten Sensitivity, today announced that the South Africa Patent and Trademark Office on issued S.A. Patent No.ZA201802192, with claims of Methods for Producing Carboxylate Ligand Modified Ferric Iron Hydroxide Colloids and Related Compositions and Uses, directed to the use of oral iron supplementation. Read More
Press Release
Aronora Announces Clinical Data to Be Presented at the 62nd American Society of Hematology Annual Meeting
Presentation to include clinical data from Aronora's phase 2 study of AB023, a factor XI-targeted antibody that is being developed for the treatment and prevention of thrombosis and inflammation. Read More
Press Release
